FdaApplication
BLA 761334
Identifiers
- fda_app_no: BLA761334
Properties
| Property | Value |
|---|---|
| applicant_name | Incyte Corporation |
| application_type | BLA |
| approval_date | 2023-03-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZYNYZ | RETIFANLIMAB-DLWR | 500MG/20ML (25MG/ML) | Injection |
1 product